澳门金沙博彩娱乐平台_-423.net-澳门金沙js8.com
423.net

Release time:2018/04/08author:admin

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to enhance the patient perspective and experience in drug development and review-423.net-金沙澳门官网js8

Benefit-risk assessment is at the heart of what we do to ensure that Americans have access to medical products that are safe, effective and meet their needs.-澳门金沙js8.com-423.net

But we’re also deeply aware that serious chronic illnesses aren’t monolithic. Patient perception of the benefits and risks of different treatment options can vary based on the stage of the disease, the age of onset, alternative therapies available to treat the disease (if any) and whether a novel therapy improves a patient’s ability to function normally, slows the rate of disease progression or impacts other aspects of a patient’s quality of life.-澳门金沙博彩娱乐平台_

A 45-year-old father of two who is diagnosed with aggressive prostate cancer may have very different goals than an 80-year-old man diagnosed with the same disease. 

To address these realities, we’ll continue working in close partnership with patients to incorporate their experience into our benefit-risk assessments. We know that first-hand knowledge of living with a serious illness – communicated in science-based terms that patients value and understand – is integral to facilitating the successful development of safe and effective products that can deliver meaningful benefits in each disease, or disease state. 

Today we have many more tools to measure these patient benefits – including wearable devices, medical apps and even machine-learning programs. These tools can bring us a better understanding of how patients experience their illness, including how it affects their day-to-day feeling or functioning and how a given treatment may impact the course of that illness.

Tools -金沙澳门官网js8for -金沙澳门官网js8capturing -金沙澳门官网js8the -金沙澳门官网js8patient -金沙澳门官网js8experience -金沙澳门官网js8may -金沙澳门官网js8be -金沙澳门官网js8quantitative -金沙澳门官网js8or -金沙澳门官网js8qualitative, -金沙澳门官网js8but -金沙澳门官网js8they -金沙澳门官网js8are -金沙澳门官网js8transforming -金沙澳门官网js8nearly -金沙澳门官网js8every -金沙澳门官网js8aspect -金沙澳门官网js8of -金沙澳门官网js8medical -金沙澳门官网js8product -金沙澳门官网js8development. -金沙澳门官网js8Patients -金沙澳门官网js8are -金沙澳门官网js8teaching -金沙澳门官网js8us -金沙澳门官网js8about -金沙澳门官网js8the -金沙澳门官网js8benefits -金沙澳门官网js8that -金沙澳门官网js8matter -金沙澳门官网js8most -金沙澳门官网js8to -金沙澳门官网js8them -金沙澳门官网js8and -金沙澳门官网js8the -金沙澳门官网js8risks -金沙澳门官网js8that -金沙澳门官网js8they -金沙澳门官网js8are -金沙澳门官网js8most -金沙澳门官网js8concerned -金沙澳门官网js8about. -金沙澳门官网js8Patients -金沙澳门官网js8are, -金沙澳门官网js8rightly -金沙澳门官网js8so, -金沙澳门官网js8becoming -金沙澳门官网js8the -金沙澳门官网js8driving -金沙澳门官网js8force -金沙澳门官网js8of -金沙澳门官网js8the -金沙澳门官网js8medical -金沙澳门官网js8research -金沙澳门官网js8enterprise.  
-金沙澳门官网js8
-金沙澳门官网js8